These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 19616541)
21. Involvement of p42/p44 MAPK, JNK, and NF-kappaB in IL-1beta-induced ICAM-1 expression in human pulmonary epithelial cells. Lin FS; Lin CC; Chien CS; Luo SF; Yang CM J Cell Physiol; 2005 Feb; 202(2):464-73. PubMed ID: 15389584 [TBL] [Abstract][Full Text] [Related]
23. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways. Kim YJ; Hwang SY; Oh ES; Oh S; Han IO J Neurosci Res; 2006 Oct; 84(5):1037-46. PubMed ID: 16881054 [TBL] [Abstract][Full Text] [Related]
24. Mesalazine Activates Adenosine Monophosphate-activated Protein Kinase: Implication in the Anti-inflammatory Activity of this Anti-colitic Drug. Park H; Kim W; Kim D; Jeong S; Jung Y Curr Mol Pharmacol; 2019; 12(4):272-280. PubMed ID: 30848228 [TBL] [Abstract][Full Text] [Related]
25. Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. Huang NL; Chiang SH; Hsueh CH; Liang YJ; Chen YJ; Lai LP Int J Cardiol; 2009 May; 134(2):169-75. PubMed ID: 18597869 [TBL] [Abstract][Full Text] [Related]
26. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108 [TBL] [Abstract][Full Text] [Related]
27. Anti-inflammatory effects of besifloxacin, a novel fluoroquinolone, in primary human corneal epithelial cells. Zhang JZ; Cavet ME; Ward KW Curr Eye Res; 2008 Nov; 33(11):923-32. PubMed ID: 19085374 [TBL] [Abstract][Full Text] [Related]
28. Effect of taurine chloramine on the production of matrix metalloproteinases (MMPs) in adiponectin- or IL-1beta-stimulated fibroblast-like synoviocytes. Kim KS; Choi HM; Oh DH; Kim C; Jeong JS; Yoo MC; Yang HI J Biomed Sci; 2010 Aug; 17 Suppl 1(Suppl 1):S27. PubMed ID: 20804602 [TBL] [Abstract][Full Text] [Related]
29. Taurine chloramine modulates the expression of adipokines through inhibition of the STAT-3 signaling pathway in differentiated human adipocytes. Kim KS; Ji HI; Chung H; Kim C; Lee SH; Lee YA; Yang HI; Yoo MC; Hong SJ Amino Acids; 2013 Dec; 45(6):1415-22. PubMed ID: 24178768 [TBL] [Abstract][Full Text] [Related]
30. Oxidation of Ikappa Balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation. Kanayama A; Inoue J; Sugita-Konishi Y; Shimizu M; Miyamoto Y J Biol Chem; 2002 Jul; 277(27):24049-56. PubMed ID: 11983684 [TBL] [Abstract][Full Text] [Related]
31. Adjunct therapy of n-3 fatty acids to 5-ASA ameliorates inflammatory score and decreases NF-κB in rats with TNBS-induced colitis. Mbodji K; Charpentier C; Guérin C; Querec C; Bole-Feysot C; Aziz M; Savoye G; Déchelotte P; Marion-Letellier R J Nutr Biochem; 2013 Apr; 24(4):700-5. PubMed ID: 22841543 [TBL] [Abstract][Full Text] [Related]
32. 5-Aminosalicylic Acid Azo-Coupled with a GPR109A Agonist Is a Colon-Targeted Anticolitic Codrug with a Reduced Risk of Skin Toxicity. Jeong S; Lee H; Kim S; Ju S; Kim W; Cho H; Kim HY; Heo G; Im E; Yoo JW; Yoon IS; Jung Y Mol Pharm; 2020 Jan; 17(1):167-179. PubMed ID: 31743034 [TBL] [Abstract][Full Text] [Related]
33. Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats. Song M; Xia B; Li J Postgrad Med J; 2006 Feb; 82(964):130-5. PubMed ID: 16461476 [TBL] [Abstract][Full Text] [Related]
34. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy. Karrout Y; Dubuquoy L; Piveteau C; Siepmann F; Moussa E; Wils D; Beghyn T; Neut C; Flament MP; Guerin-Deremaux L; Dubreuil L; Deprez B; Desreumaux P; Siepmann J J Control Release; 2015 Jan; 197():121-30. PubMed ID: 25445696 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of glycine-bearing celecoxib derivatives as a colon-specific mutual prodrug acting on nuclear factor-κB, an anti-inflammatory target. Lee S; Lee Y; Kim W; Nam J; Jeong S; Yoo JW; Kim MS; Moon HR; Jung Y Drug Des Devel Ther; 2015; 9():4227-37. PubMed ID: 26300626 [TBL] [Abstract][Full Text] [Related]
36. Colon-targeted cell-permeable NFκB inhibitory peptide is orally active against experimental colitis. Hong S; Yum S; Yoo HJ; Kang S; Yoon JH; Min D; Kim YM; Jung Y Mol Pharm; 2012 May; 9(5):1310-9. PubMed ID: 22428658 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid. Jung YJ; Kim HH; Kong HS; Kim YM Arch Pharm Res; 2003 Apr; 26(4):264-9. PubMed ID: 12735682 [TBL] [Abstract][Full Text] [Related]
39. Protective Effects of Taurine Chloramine on Experimentally Induced Colitis: NFκB, STAT3, and Nrf2 as Potential Targets. Kim SH; Yum HW; Kim SH; Kim W; Kim SJ; Kim C; Kim K; Suh YG; Surh YJ Antioxidants (Basel); 2021 Mar; 10(3):. PubMed ID: 33803551 [TBL] [Abstract][Full Text] [Related]
40. Aminosalicylic acid inhibits IkappaB kinase alpha phosphorylation of IkappaBalpha in mouse intestinal epithelial cells. Yan F; Polk DB J Biol Chem; 1999 Dec; 274(51):36631-6. PubMed ID: 10593965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]